These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18208241)

  • 1. The nature of the coagulation defect in hemophilia; studies on platelet-free plasmas.
    HARTMAN RC; CONLEY CL; LALLEY JS
    Am J Med; 1949 Apr; 6(4):507. PubMed ID: 18208241
    [No Abstract]   [Full Text] [Related]  

  • 2. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets.
    BRINKHOUS KM
    Fed Proc; 1947; 6(1):389. PubMed ID: 20343817
    [No Abstract]   [Full Text] [Related]  

  • 3. Clotting defect in hemophilia; deficiency in a plasma factor required for platelet utilization.
    BRINKHOUS KM
    Proc Soc Exp Biol Med; 1947 Oct; 66(1):117-20. PubMed ID: 20270694
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; the effect in vitro and in vivo on the coagulation time in hemophilia of a prothrombin and fibrinogen-free normal plasma and its derived protein fractions.
    LEWIS JH; SOULIER JP; TAYLOR FH
    J Clin Invest; 1946 Nov; 25(6):876-9. PubMed ID: 20282730
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of convertin with platelets and with platelet-free and hemophilic plasma.
    DE VRIES A; KREJNIS E; SHAFRIR E
    Acta Haematol; 1956 Sep; 16(3):204-13. PubMed ID: 13354260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)].
    Fabris F; Betterle C; Casonato A; De Marco L; Girolami A
    Ric Clin Lab; 1979; 9(2 Suppl):51-63. PubMed ID: 395621
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
    Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
    Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of certain fractions of the plasma globulins to the coagulation defect in hemophilia.
    LEWIS JH; TAGNON HJ
    Blood; 1946 Mar; 1():166-72. PubMed ID: 21015979
    [No Abstract]   [Full Text] [Related]  

  • 9. COAGULATION STUDIES IN HEMOPHILIOID DISEASES: THEIR IMPORTANCE IN TREATMENT PLANNING.
    MEYER I
    J Oral Surg Anesth Hosp Dent Serv; 1964 Jul; 22():324-31. PubMed ID: 14155476
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the influence of histamine on platelet activity, with especial reference to its action on the blood of the hemophiliac patient.
    SANFORD HN; HALL FR; BUTLER S
    Pediatrics; 1952 Feb; 9(2):212-9. PubMed ID: 14911283
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged bleeding time in children and young adults with hemophilia.
    Buchanan GR; Holtkamp CA
    Pediatrics; 1980 Dec; 66(6):951-5. PubMed ID: 7454486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 13. [A suggestion for the uniform laboratory diagnosis of hemophilia].
    Lutze G; Schlote A
    Z Gesamte Inn Med; 1980 Apr; 35(8):340-5. PubMed ID: 7434843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural aspects of interactions of platelets with microcrystalline collagen.
    Zucker WH; Mason RG
    Am J Pathol; 1976 Jan; 82(1):129-42. PubMed ID: 1082242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLATELET SURVIVAL STUDIES IN COAGULATION DISORDERS, THROMBOCYTHEMIA, AND CONDITIONS ASSOCIATED WITH ATHEROSCLEROSIS.
    O'NEILL B; FIRKIN B
    J Lab Clin Med; 1964 Aug; 64():188-201. PubMed ID: 14202782
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-delivered therapeutics.
    Lyde R; Sabatino D; Sullivan SK; Poncz M
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S143-50. PubMed ID: 26149015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent hemophilia and qualitative platelet disturbance.
    DJERASSI I; DE VRIES A; FISHER I; REMEZ D
    Acta Haematol; 1957 Nov; 18(5):354-8. PubMed ID: 13487188
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin utilization following addition of platelet confactor I concentrates to hemophilic plasma.
    JOHNSON JF; MAMMEN EF; SEEGERS WH
    Thromb Diath Haemorrh; 1959 Sep; 3():588-92. PubMed ID: 14407473
    [No Abstract]   [Full Text] [Related]  

  • 19. [RECENT DATA ON THE HEREDITARY ASPECTS OF HEMOPHILIA].
    REMDE W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():89-93. PubMed ID: 14117155
    [No Abstract]   [Full Text] [Related]  

  • 20. [SHORT SURVEY ON RESEARCH LEADING TO A CLARIFICATION OF HEMOPHILIA].
    KUKOWKA A
    Z Gesamte Inn Med; 1963 Aug; 18():730-8. PubMed ID: 14083669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.